Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
11
×
fda
11
×
life sciences
national blog main
clinical trials
national top stories
boston
new york blog main
new york top stories
san francisco blog main
deals
san francisco top stories
cancer
eli lilly
novartis
san diego blog main
san diego top stories
alexion pharmaceuticals
alnylam pharmaceuticals
amgen
biotech ipos
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer drugs
detroit blog main
detroit top stories
drug discovery
europe blog main
gilead sciences
hepatitis b
indiana blog main
indiana top stories
investing
ipo
national
new york
nonalcoholic steatohepatitis
What
medicines
11
×
drug
fda
ipo
new
pharmaceuticals
research
approval
brings
cancer
candidate
company
deal
developing
disease
helped
lead
muscle
pharma
ready
roche
team
therapeutics
acquire
activity
agreed
alternative
amgen
approvals
autoimmune
billion
bio
biogen
biotech
biotechs
black
blueprint
candidates
cash
caught
Language
unset
unknown
Current search:
medicines
×
" boston top stories "
×
fda
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines